You are here

Article Text

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Hydroxychloroquine shortages during the COVID-19 pandemic’ by Mendel et al
  1. Iain McInnes
  1. Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8QQ, UK
  1. Correspondence to Professor Iain McInnes, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8QQ, UK; iain.mcinnes{at}glasgow.ac.uk

https://doi.org/10.1136/annrheumdis-2020-217954

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    As the COVID-19 crisis moves to its next phase, from ‘acute to chronic’ as it were, it is important to note that a variety of immune modifier medicines are now being proposed or actively trialled in pursuit of a novel effective intervention for early through to poor prognosis coronavirus infection. Such imaginative and creative approaches are to be welcomed. Given the current mathematical models of COVID-19 pandemic resolution, it seems that this may be a lengthy scenario. In the meantime, some disease-modifying antirheumatic drugs (DMARD) are being …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors Wrote letter.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles

    • Correspondence
      Hydroxychloroquine shortages during the COVID-19 pandemic
      Arielle Mendel Sasha Bernatsky J Carter Thorne Diane Lacaille Sindhu R Johnson Évelyne Vinet
      Annals of the Rheumatic Diseases 2020; 80 e31-e31 Published Online First: 20 May 2020. doi: 10.1136/annrheumdis-2020-217835